Since their introduction, GLP-1 medications have rapidly gained popularity for their effectiveness in helping people manage ...

A large US-based study has found that people with type 2 diabetes taking GLP-1 drugs such as Ozempic may be slightly less ...

Novo Nordisk has officially launched Ozempic in India for diabetes care. Here's how the injectable works, its dosage options, ...

Researchers have developed a new oral drug that boosts metabolic activity in muscle rather than altering appetite like GLP-1 ...

The European Medicines Agency's committee on Friday recommended extending the use of Eli Lilly's blockbuster drug Mounjaro ...

Diabetes goes beyond just glucose control, and recent advancements in research are enhancing drug development for the disease.

For an older person with type 2 diabetes, especially someone already at risk of frailty, a GLP 1 or SGLT 2 medicine, where ...

Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 per week and targeting a booming ...

Launch targets $16 billion SGLT-2 inhibitor market that serves 33 million type II diabetics in the US, many of whom are uninsured and underinsured and whose out-of-pocket costs exceed Brenzavvy‘s cash ...

Global diabetes drug Ozempic (semaglutide) has now been launched in India by Danish pharmaceutical major Novo Nordisk. In an exclusive interaction with NDTV, Managing Director of Novo Nordisk India, ...

Head of Clinical Services, Dementia Support Australia, & Associate Professor of Psychiatry, Monash University A Korean study published recently suggests people with type 2 diabetes who are prescribed ...

Metformin is a trusted treatment for type 2 diabetes, but some people are being prescribed the drug for weight loss. (Getty Images) But what exactly does metformin do, and is it effective for weight ...